Chronic Pain Programs

Number: 0237

Policy

Aetna considers a screening examination medically necessary for members who are being considered for admission into a chronic pain program.

  1. Outpatient Pain Management Programs

    Aetna considers outpatient multi-disciplinary pain management programs medically necessary when all of the following criteria are met:

    • If a surgical procedure or acute medical treatment is indicated, it has been performed prior to entry into the pain program; and
    • Member has experienced chronic non-malignant pain (not cancer pain) for 6 months or more; and
    • Member has failed conventional methods of treatment; and
    • Member has undergone a mental health evaluation, and any primary psychiatric conditions have been treated, where indicated; and
    • Member's work or lifestyle has been significantly impaired due to chronic pain; and 
    • Referral for entry has been made by the primary care physician/attending physician; and
    • The cause of the member's pain is unknown or attributable to a physical cause, i.e., not purely psychogenic in origin.

    Aetna considers entry into an outpatient multi-disciplinary chronic pain program of no proven benefit for members with any of the following contraindications:

    • Member exhibits aggressive and/or violent behavior; or
    • Member exhibits imminently suicidal tendencies; or
    • Member has previously failed an adequate multi-disciplinary (e.g., Commission on Accreditation of Rehabilitation Facilities (CARF) accredited) chronic pain management program; or
    • Member has unrealistic expectations of what can be accomplished from the program (i.e., member expects an immediate cure); or
    • Member is medically unstable (e.g., due to uncontrollable high blood pressure, unstable congestive heart failure, or other medical conditions); or
    • Member is unable to understand and carry out instructions.

    Pain is considered chronic if it results from a chronic pathological process, has recurred periodically over months or years, or persists longer than expected after an illness or injury. Typically, pain is considered chronic if it has persisted for 6 months or more.

    Modality-oriented pain clinics and single disciplinary pain clinics are considered not medically necessary and inappropriate for comprehensive treatment of members with chronic pain.

    Note: Dependence on narcotics or other controlled substances is frequently part of the presentation of a person with chronic pain. In persons with moderate to severe substance use disorders, detoxification must be considered and evaluated prior to enrollment into a pain management program. Refer to an Addiction Medicine specialist should be strongly considered in these persons. 

  2. Inpatient Pain Management Programs

    Aetna considers entry into an inpatient multi-disciplinary pain management program for up to 21 days medically necessary when members meet the above criteria for entry into an outpatient pain management program as well as all of the following criteria:

    • Member has major functional disabilities; and
    • Member needs extensive psychological or behavioral therapy; and
    • Member needs temporary removal from a detrimental home situation to re-focus their lives away from the pain; and
    • The pain has caused extensive disruption in family functioning.

    Note: Most inpatient chronic pain treatment programs require both medical and psychological evaluations before admission into the program.  These evaluations should be performed on an outpatient basis; inpatient admission for these evaluations is considered not medically necessary.  Participation in inpatient pain management programs for more than 21 days is subject to medical necessity review.  Continued inpatient chronic pain treatment is considered not medically necessary for members who are not participating (e.g., failure to attend scheduled treatment sessions) in the program.  An inpatient chronic pain management program is considered not medically necessary for persons who have failed a prior adequate multi-disciplinary (e.g., CARF accredited) chronic pain management program.

    Note: Neuropsychological evaluation/testing is of no proven benefit for members with chronic pain being considered for treatment solely with narcotic pain medication.  See CPB 0158 - Neuropsychological and Psychological Testing.

    Aetna considers Foundation PISM (Ethos Laboratories) functional biomarker urine test panel experimental and investigational for chronic pain management and for all other indications.

Background

Pain is considered chronic if it persists longer than expected after an illness or injury, if it is associated with a chronic pathological process, or if it flares up periodically over months to years.  Typically, pain is considered chronic if it has lasted 6 months or more.  Chronic pain may be caused by physical, psychological, and environmental factors.  It can be categorized as malignant or non-malignant in etiology.  Chronic non-malignant pain encompasses many painful disorders such as back pain, migraine headaches, diabetic neuropathy, dental and orofacial pain, arthritic pain and pain due to musculo-skeletal/rheumatic disorders.

Pain rehabilitation programs are a relatively new and innovative approach to the treatment of chronic, intractable non-malignant pain.  The goal of such programs is to give patients the tools to manage and control their pain and thereby improve their ability to function independently.  Comprehensive treatment of chronic pain must address both physical and psychological aspects; thus, inter-disciplinary approaches to pain management involve medical management, physical therapy, occupational therapy, biofeedback, vocational and recreational therapy, and psychological counseling.  Collaboration among therapists, psychologists, and other supportive resources is important to delivering effective pain treatments.

Chronic pain patients often have psychological problems that accompany or stem from physical pain.  Hence, it is appropriate to include psychological treatment in the multi-disciplinary approach to pain management.  However, patients whose pain results solely or primarily from psychiatric disorders rather than physical conditions generally can not be successfully treated in a pain rehabilitation program.

Hospital-level pain rehabilitation programs use coordinated multi-disciplinary teams to deliver, in a controlled environment, a concentrated program to modify pain behavior, which addresses physiological, psychological, and social factors that may contribute to the patient's pain.  Such programs generally include diagnostic testing, skilled nursing, psychotherapy, structured progressive withdrawal from pain medications, physical therapy and occupational therapy to restore physical fitness (mobility and endurance) to a maximal level within the constraints of a patient's physical disability, and the use of mechanical devices and/or activities to relieve pain or modify a patient's reaction to it (e.g., nerve stimulation, hydrotherapy, massage, ice, systemic muscle relaxation training, and diversional activities).  The program's day-to-day activities are under the general supervision and, as needed, direct supervision of a physician.

The literature suggests that generally up to 3 weeks of inpatient care may be required to modify pain behavior.  Any chronic pain rehabilitation that may be needed after that can usually be effectively provided on an outpatient basis.  Although many multi-disciplinary pain facilities have both inpatient and outpatient treatment programs, there is little evidence that inpatient programs are more effective than outpatient programs.  Outpatient pain rehabilitation programs frequently provide services in group settings, even though these services are being furnished pursuant to each patient's individualized plan of treatment.

There is sufficient evidence that multi-disciplinary pain treatment clinics/centers are effective for the management of appropriately selected patients with chronic non-malignant pain.  Studies have shown that chronic pain patients who have completed these programs have lasting reductions in pain and psychological distress.  These studies have demonstrated improvements both in subjective ratings of pain and in objective measures such as reduced use of narcotic pain medications, increased rates of return-to-work, and decreased utilization of the health care system. 

A systematic evidence review by the Swedish Council on Technology Assessment in Health Care (SBU, 2006) concluded that "rehabilitation programs, referred to as multimodal rehabilitation (usually a combination of psychological interventions and physical activity, physical exercise or physical therapy) is that pain decreases more, a greater number of people return to work and sick leaves are shorter than with passive control and/or limited, separate interventions."  The SBU assessment also found that multi-modal rehabilitation improves long-term functional ability in fibromyalgia patients more effectively than passive control or limited, separate interventions.

An assessment of multidisciplinary pain programs for chronic non-cancer pain, preparted for the Agency for Healthcare Research and Quality (Jeffery, et al, 2011) found that multidisciplinary pain programs have been extensively documented in the standard medical literature. The 183 papers considered in the AHRQ assessment followed a biopsychosocial model of chronic pain, including treatment components in each of four areas: medical, behavioral, physical reconditioning, and education. Most of the studies considered in the AHRQ assessment were observational before-after designs. Although several different clinical conditions were studied, 90 percent of the studies included chronic back pain, the most frequent condition addressed in the literature. The report noted that differences were apparent between studies based in the United States and those in Europe; recent European studies were more likely than U.S. studies to include inpatient delivery of multidisciplinary pain program treatment. Declining access to multidisciplinary pain program treatment in the United States is highlighted as a key issue faced by those in the community of chronic pain sufferers and researchers.

Heutink et al (2012) evaluated a multi-disciplinary cognitive behavioral treatment program for persons with chronic neuropathic pain after spinal cord injury (SCI).  The intervention consisted of educational, cognitive, and behavioral elements.  A total of 61 people were randomized to either the intervention group or the waiting list control group in 4 Dutch rehabilitation centers.  Primary outcomes were pain intensity and pain-related disability (Chronic Pain Grade questionnaire), and secondary outcomes were mood (Hospital Anxiety and Depression Scale), participation in activities (Utrecht Activities List), and life satisfaction (Life Satisfaction Questionnaire).  Measurements were performed at baseline, and at 3, and 6 months follow-up.  The primary statistical technique was random co-efficient analysis.  The analyses showed significant changes over time on both primary (t1 - t2), and 2 out of 4 secondary outcomes (both t1-t2 and t1-t3).  Significant intervention effects (Time*Group interactions) were found for anxiety and participation in activities, but not for the primary outcomes.  Subsequent paired-t tests showed significant changes in the intervention group that were not seen in the control group: decrease of pain intensity, pain-related disability, anxiety, and increase of participation in activities.  The authors concluded that these findings implied that a multi-disciplinary cognitive behavioral program might have beneficial effects on people with chronic neuropathic SCI pain.

Foundation PISM

Foundation PISM is a urine test analysis by liquid chromatography tandem mass spectrometry (LCM/MS) of 11 endogenous analytes (methylmalonic acid, xanthurenic acid, homocysteine, pyroglutamic acid, vanilmandelate, 5- hydroxyindoleacetic acid, hydroxymethylglutarate, ethylmalonate, 3- hydroxypropyl mercapturic acid (3-HPMA), quinolinic acid, kynurenic acid). Results of an algorithm are reported as a pain-index score that is intended to indicate the likelihood of atypical biochemical function associated with pain. There is a lack of evidence in the peer-reviewed published medical literature of the clinical validity and utility of this test.

Gunn, et al. (2020) reported on a retrospective observational study to determine and evaluate the prevalence of abnormal biomarker findings in a population of patients with chronic pain. Investigators employed a pain-specific biomarker test panel that evaluates biomarkers of systemic inflammation, oxidative stress, neurotransmitter turnover, and micronutrient status to determine the prevalence of abnormal findings in 17,834 unique patient samples analyzed at a national reference laboratory (Ethos Laboratories, Newport, KY). Patient biomarker results were considered abnormal if they were outside of the 95% confidence interval reference ranges established using a healthy population of donors who had no history of chronic pain or opioid use. The investigators found that 77% of patients with chronic pain exhibited at least one abnormal biomarker result (n = 13,765). The most common abnormal biomarker finding was elevated quinolinic acid, which was observed in 29% of patients (n = 5,107). Elevated pyroglutamate, indicative of glutathione depletion, was observed in 19% of patients (n = 3,314). Elevated xanthurenic acid, indicative of vitamin B6 insufficiency, was observed in 17% of patients (3,025). Elevated levels of the acrolein metabolite 3-hydroxypropyl mercapturic acid were observed in 21% of patients (n = 3,667). Elevated methylmalonic acid, indicative of a vitamin B12 deficiency, was observed in 10% of patients (n = 1,827), whereas abnormally low levels of neurotransmitter metabolites were observed in 8% of patients (n = 1,456). The investigators noted that a limitation of this study was that medications and conditions other than those associated with chronic pain were not evaluated as potential causes of abnormal biomarker findings.

Table: CPT Codes / HCPCS Codes / ICD-10 Codes
Code Code Description

Information in the [brackets] below has been added for clarification purposes.   Codes requiring a 7th character are represented by "+":

CPT codes not covered for indications listed in the CPB:
0117U Pain management, analysis of 11 endogenous analytes (methylmalonic acid, xanthurenic acid, homocysteine, pyroglutamic acid, vanilmandelate, 5-hydroxyindoleacetic acid, hydroxymethylglutarate, ethylmalonate, 3-hydroxypropyl mercapturic acid (3-HPMA), quinolinic acid, kynurenic acid), LC-MS/MS, urine, algorithm reported as a pain-index score with likelihood of atypical biochemical function associated with pain
96132 - 96133 Neuropsychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed
96146 Psychological or neuropsychological test administration, with single automated, standardized instrument via electronic platform, with automated result only

Other CPT codes related to the CPB:
64553 - 64595 Neurostimulators
90785 Interactive complexity (list separately in addition to the code for primary procedure)
90791 Psychiatric diagnostic evaluation
90792 Psychiatric diagnostic evaluation with medical services
90832 - 90838 Psychotherapy
90845 - 90853 Psychotherapy for crisis
96156 - 96171 Health behavior assessment, or re-assessment and intervention
97010 - 97546 Therapeutic procedures

ICD-10 codes covered if selection criteria are met:
G89.21 - G89.3 Chronic pain, not elsewhere classified
G89.4 Chronic pain syndrome

The above policy is based on the following references:

  1. Agency for Healthcare Research and Quality (AHRQ). Management of chronic central neuropathic pain following traumatic spinal cord injury. Evidence Report/Technology Assessment 45. Rockville, MD: AHRQ; 2001.  
  2. Aronoff GM, Feldman JB, Campion TS. Management of chronic pain and control of long-term disability. Occup Med. 2000;15(4):755-770, iv. 
  3. Aronoff GM, McAlary PW, Witkower A, et al. Pain treatment programs: Do they return workers to the workplace? Occup Med. 1988;3(1):123-136. 
  4. Bennett RM. Multidisciplinary group programs to treat fibromyalgia patients. Rheum Dis Clin North Am. 1996;22(2):351-367.  
  5. Brady A, Cleeland C, Goldstein G, et al. Pain management guidelines: Implications for managed care--a roundtable discussion. Med Interface. 1997;Suppl:10-32. 
  6. Burns JW, Sherman ML, Devine J, et al. Association between workers' compensation and outcome following multidisciplinary treatment for chronic pain: Roles of mediators and moderators. Clin J Pain. 1995;11(2):94-102.  
  7. Cormier S, Lavigne GL, Choiniere M, Rainville P. Expectations predict chronic pain treatment outcomes. Pain. 2016;157(2):329-338.
  8. Crook J, Tunks E. Pain clinics. Rheum Dis Clin North Am. 1996;22(3):599-611.  
  9. Csordas TJ, Clark JA. Ends of the line: Diversity among chronic pain centers. Soc Sci Med. 1992;34(4):383-393.  
  10. Danish Centre for Evaluation and Health Technology Assessment (DACEHTA). Pain school -- a health technology assessment [summary]. Hague, the Netherlands; DACEHTA; 2006.
  11. Deardorff WW, Rubin HS, Scott DW. Comprehensive multidisciplinary treatment of chronic pain: A follow-up study of treated and non-treated groups. Pain. 1991;45(1):35-43.  
  12. Dobkin PL, Boothroyd LJ. Management of chronic pain: Organization of health services. AETMIS 06-04. Montreal, QC: Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante (AETMIS); 2006.
  13. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep. 2016;65(1):1-49.
  14. Dysvik E, Natvig GK, Eikeland OJ, Brattberg G. Results of a multidisciplinary pain management program: A 6- and 12-month follow-up study. Rehabil Nurs. 2005;30(5):198-206.
  15. Ethos Laboratories. Pain biomarker assessment [website]. Newport, KY: Ethos Laboratories; 2020. Available at: https://www.ethos-labs.com/services/. Accessed March 9, 2020.
  16. Fedoroff IC, Blackwell E, Speed B. Evaluation of group and individual change in a multidisciplinary pain management program. Clin J Pain. 2014;30(5):399-408.
  17. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: A meta-analytic review. Pain. 1992;49(2):221-230.  
  18. French S. Multidisciplinary care for chronic low back pain. Evidence Centre Clinical Appraisal. Clayton, VIC: Centre for Clinical Effectiveness (CCE); October 2003.
  19. Friedrich M, Gittler G, Arendasy M, Friedrich KM.  Long-term effect of a combined exercise and motivational program on the level of disability of patients with chronic low back pain. Spine. 2005;30(9):995-1000.
  20. Gagnon S, Lensel-Corbeil G, Duquesnoy B, et al. Multicenter multidisciplinary training program for chronic low back pain: French experience of the Renodos back pain network (Réseau Nord Pas-de-Calais du DOS). Ann Phys Rehabil Med. 2009;52(1):3-16.
  21. Gallagher RM. Primary care and pain medicine. A community solution to the public health problem of chronic pain. Med Clin North Am. 1999;83(3):555-583, v.  
  22. Gardea MA, Gatchel RJ. Interdisciplinary treatment of chronic pain. Curr Rev Pain. 2000;4(1):18-23. 
  23. Grzesiak RC. Strategies for multidisciplinary pain management. Compendium. 1989;10(8):444, 446-448, 450.  
  24. Gunn J, Hill MM, Cotten BM, Deer TR. An analysis of biomarkers in patients with chronic pain. Pain Physician. 2020;23(1):E41-E49.
  25. Gunreben-Stempfle B, Griessinger N, Lang E, et al. Effectiveness of an intensive multidisciplinary headache treatment program. Headache. 2009;49(7):990-1000.
  26. Guzmán J, Esmail R, Karjalainen K, et al.  Multidisciplinary bio-psycho-social rehabilitation for chronic low back pain. Cochrane Database Syst Rev. 2006;(2):CD00963.
  27. Hadjistavropoulos HD, Clark J. Using outcome evaluations to assess interdisciplinary acute and chronic pain programs. Jt Comm J Qual Improv. 2001;27(7):335-348.
  28. Hazard RG. Chronic low back pain and disability: The efficacy of functional restoration. Bull Hosp Jt Dis. 1996;55(4):213-216.  
  29. Heutink M, Post MW, Bongers-Janssen HM, et al. The CONECSI trial: Results of a randomized controlled trial of a multidisciplinary cognitive behavioral program for coping with chronic neuropathic pain after spinal cord injury. Pain. 2012;153(1):120-128.
  30. Homik J. Reflex sympathetic dystrophy. Edmonton, AB: Alberta Heritage Foundation for Medical Research (AHFMR); 1998.
  31. International Association for the Study of Pain. Task Force on Guidelines for Desirable Characteristics for Pain Treatment Facilities, 1990. 
  32. Jeffery MM, Butler M, Stark A, Kane RL. Multidisciplinary Pain Programs for Chronic Noncancer Pain. Technical Brief No. 8. Prepared by Minnesota Evidence-based Practice Center under Contract No. 290-07-10064-I. AHRQ Publication No. 11-EHC064-EF. Rockville, MD: Agency for Healthcare Research and Quality; September 2011.
  33. Jensen MP, Turner JA, Romano JM. Correlates of improvement in multidisciplinary treatment of chronic pain. J Consult Clin Psychol. 1994;62(1):172-179.  
  34. Kamper SJ, Apeldoorn AT, Chiarotto A, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. Cochrane Database Syst Rev. 2014;9:CD000963.
  35. Karjalainen K, Malmivaara A, van Tulder M, et al. Multidisciplinary biopsychosocial rehabilitation for subacute low-back pain among working age adults. Cochrane Database Syst Rev. 2003;(2):CD002193.
  36. Karjalainen K, Malmivaara A, van Tulder M, et al. Multidisciplinary biopsychosocial rehabilitation for neck and shoulder pain among working age adults. Cochrane Database Syst Rev. 2003;(2):CD002194.
  37. Karjalainen KA, Hurri H, Jauhiainen M, et al. Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database Syst Rev.1999;(3):CD001984.
  38. Langelier RP, Gallagher RM. Outpatient treatment of chronic pain groups for couples. Clin J Pain. 1989;5(3):227-231. 
  39. Logan DE, Conroy C, Sieberg CB, Simons LE. Changes in willingness to self-manage pain among children and adolescents and their parents enrolled in an intensive interdisciplinary pediatric pain treatment program. Pain. 2012;153(9):1863-1870.
  40. Management of Medically Unexplained Symptoms: Chronic Pain and Fatigue Working Group. VHA/DoD clinical practice guideline for the management of medically unexplained symptoms: chronic pain and fatigue. Washington, DC: Veterans Health Administration (VHA), Department of Defense (DoD); July 2001.
  41. Melzack R. Pain--an overview. Acta Anaesthesiol Scand. 1999;43(9):880-884. 
  42. Nicholson K. At the crossroads: Pain in the 21st century. NeuroRehabilitation. 2000;14(2):57-67.  
  43. Norlund A, Ropponen A, Alexanderson K. Multidisciplinary interventions: Review of studies of return to work after rehabilitation for low back pain. J Rehab Med. 2009;41(3):115-121.
  44. Ospina M, Harstall C. Multidisciplinary pain programs for chronic pain: Evidence from systematic reviews. HTA 30. Edmonton, AB: Alberta Heritage Foundation for Medical Research (AHFMR); 2003.
  45. Patrick LE, Altmaier EM, Found EM. Long-term outcomes in multidisciplinary treatment of chronic low back pain: Results of a 13-year follow-up. Spine. 2004;29(8):850-855.
  46. Peat GM, Moores L, Goldingay S, et al. Pain management program follow-ups. A national survey of current practice in the United Kingdom. J Pain Symptom Manage. 2001;21(3):218-226. 
  47. Peters JL, Large RG. A randomized control trial evaluating in- and outpatient pain management programmes. Pain. 1990;41(3):283-293.  
  48. Pieh C, Altmeppen J, Neumeier S, et al. Gender differences in outcomes of a multimodal pain management program. Pain. 2012;153(1):197-202.
  49. Ravenek MJ, Hughes ID, Ivanovich N, et al. A systematic review of multidisciplinary outcomes in the management of chronic low back pain. Work. 2010;35(3):349-367.
  50. Reinking J, Tempkin A, Tempkin T. Rehabilitation management of chronic pain syndromes. Nurse Pract Forum. 1995;6(3):139-144.  
  51. Rosomoff RS. Inpatient and outpatient chronic pain programs can be successful in returning patients to gainful employment. Clin J Pain. 1990;6(1):80-83.  
  52. Rowlingson JC, Hamill RJ. Organization of a multidisciplinary pain center. Mount Sinai J Med. 1991;58(3):267-272.  
  53. Roy R. Pain clinics: Reassessment of objectives and outcomes. Arch Phys Med Rehabil. 1984;65(8):448-151.  
  54. Simon JM. A multidisciplinary approach to chronic pain. Rehabil Nurs. 1989;14(1):23-28.  
  55. Snow BR, Gusmorino P, Pinter I, et al. Multidisciplinary treatment of physical and psychosocial disabilities in chronic pain patients: A follow-up report. Bull Hosp Jt Dis Orthop Inst. 1988;48(1):52-61.  
  56. Stanos S, Houle TT. Multidisciplinary and interdisciplinary management of chronic pain. Phys Med Rehabil Clin N Am. 2006;17(2):435-450, vii.
  57. Stones W, Cheong YC, Howard FM. Interventions for treating chronic pelvic pain in women. Cochrane Database Syst Rev. 2005;(2):CD000387.
  58. Storro S, Moen J, Svebak S. Effects on sick-leave of a multidisciplinary rehabilitation programme for chronic low back, neck or shoulder pain: Comparison with usual treatment. J Rehabil Med. 2004;36(1):12-16.
  59. Sullivan MJ, Reesor K, Mikail S, et al. The treatment of depression in chronic low back pain: Review and recommendations. Pain. 1992;50(1):5-13.  
  60. Suman AL, Biagi B, Biasi G, et al. One-year efficacy of a 3-week intensive multidisciplinary non-pharmacological treatment program for fibromyalgia patients. Clin Exp Rheumatol. 2009;27(1):7-14.
  61. Swedish Council on Technology Assessment in Health Care (SBU). Methods of treating chronic pain -- a systematic review. SBU Report No. 177/1+2. Stockholm, Sweden; SBU; 2006.
  62. Talo S, Puukka P, Rytokoski U, et al. Can treatment outcome of chronic low back pain be predicted? Psychological disease consequences clarifying the issue. Clin J Pain. 1994;10(2):107-121.  
  63. Townsend CO, Kerkvliet JL, Bruce BK, et al. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission. Pain. 2008;140(1):177-189.
  64. Turk DC.  Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain.  Clin J Pain.  2002;18(6):355-365.
  65. Vines SW, Cox A, Nicoll L, et al. Effects of a multimodal pain rehabilitation program: A pilot study. Rehabil Nurs. 1996;21(1):25-30, 40.